Trial Profile
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache; Migraine
- Focus Therapeutic Use
- 22 Sep 2023 Status changed from active, no longer recruiting to completed.
- 14 Apr 2021 Planned End Date changed from 1 Mar 2021 to 1 Jan 2022.
- 14 Apr 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Jan 2022.